ERNEXA THERAPEUTICS INC.

Consensus Ernexa Therapeutics Inc.

Stocks

ERNA

US1140824079

Biotechnology & Medical Research

Market Closed - Nasdaq 16:00:00 2026-10-28 EDT			5-day change	1st Jan Change
1.980 ^USD	-0.66%		-11.61%	-93.40%

10-22	Ernexa Therapeutics Highlights ERNA-101?s Path Toward The Clinic And Differentiated Cell Therapy Platform In New What This Means Segment	CI
10-06	Ernexa Therapeutics Announces ERNA-101 Preclinical Data Selected For Flash Talk Presentation At Nature Conferences? Next-Generation Cancer Therapeutics Meeting Co-Hosted By MD Anderson Cancer Center	CI

Evolution of the Average Target: Ernexa Therapeutics Inc.

Evolution of the Average Target - Ernexa Therapeutics Inc.

Evolution of the Target Price: Ernexa Therapeutics Inc.

Evolution of the Target Price - Ernexa Therapeutics Inc.

Changes in Analyst Recommendations: Ernexa Therapeutics Inc.

da4193170a1e314f90c3643d78.WU9VwbjRTw1VG620c55_qCGiuj7GEZDpon9wjqiLBa0.I2I-qvK-Cn8iacLQKuQ3yXub_Qy2WuC_zRUao9zbZNUWe2eWypMGYxd_2g~75a6d754f72572a8efc028c46a5856f2

Analysts' recommendations: Ernexa Therapeutics Inc.

22-10-12	Maxim Downgrades Brooklyn ImmunoTherapeutics to Hold from Buy	MT
21-12-29	Cantor Fitzgerald Starts Brooklyn ImmunoTherapeutics at Overweight With $9 Price Target	MT
21-10-06	Brooklyn ImmunoTherapeutics : Maxim Starts Brooklyn ImmunoTherapeutics at Buy with $20 Price Target	MT

More recommendations

Other Biotechnology & Medical Research

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	ERNEXA THERAPEUTICS INC.			-	-	+1,405.19%
	WUXI APPTEC CO., LTD.					+41.32%
	ARGENX SE					+28.63%
	LONZA GROUP AG					+9.56%
	IQVIA HOLDINGS INC.					+12.15%
	BEONE MEDICINES AG					+19.23%
	REVOLUTION MEDICINES, INC.					+39%
	CELLTRION, INC.					+42.31%
	GENMAB A/S					+6.5%
	WUXI BIOLOGICS (CAYMAN) INC.					+35.02%
	Average					+163.89%
	Weighted average by Cap.					+26.20%

See all sector performances

Analysts' Consensus

Sell

Consensus

Buy

Mean consensus

BUY

Number of Analysts

1

Last Close Price

1.993USD

Average target price

30.00USD

Spread / Average Target

+1,405.19%

High Price Target

30.00USD

Spread / Highest target

+1,405.19%

Low Price Target

30.00USD

Spread / Lowest Target

+1,405.19%

Analyst Consensus Detail

Analyst consensus - Ernexa Therapeutics Inc.

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Ernexa Therapeutics Inc.

Stock Market
Stocks
ERNA Stock
Consensus Ernexa Therapeutics Inc.

As early as today, start finding the best investment opportunities!